Altimmune to Participate in Stifel Cardiometabolic Forum

Altimmune will join a virtual Stifel cardiometabolic forum, with its fireside chat accessible to investors via an online webcast.

Rhea-AI Summary

Altimmune (ALT) will participate in a fireside chat at the Stifel 2026 Virtual Cardiometabolic Forum on Wednesday, September 30, 2026, at 10:30 a.m. ET.

The company, which is developing pemvidutide for serious liver diseases, will provide live access via a webcast in the Events section of its website.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

GAITHERSBURG, Md., Sept. 23, 2026 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today announced that management will participate in a fireside chat at the Stifel 2026 Virtual Cardiometabolic Forum on Wednesday, September 30, 2026, at 10:30 a.m. ET.

A webcast of the fireside chat will be available via the Events section of the Altimmune website.

About Altimmune
Altimmune is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company’s lead candidate, pemvidutide, is a unique dual-action investigational therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD) and alcohol-associated liver disease (ALD). For more information, please visit www.altimmune.com.

Follow @Altimmune, Inc. on LinkedIn
Follow @AltimmuneInc on X

Investor Contact:
Luis Sanay, CFA
Vice President, Investor Relations
ir@altimmune.com

Media Contact:
Real Chemistry
altimmune@realchemistry.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When and at what time is Altimmune's fireside chat at the Stifel 2026 Virtual Cardiometabolic Forum?

The fireside chat is scheduled for Wednesday, September 30, 2026, at 10:30 a.m. ET.

How can investors access the Altimmune fireside chat webcast?

A webcast of the fireside chat will be available through the Events section of the Altimmune website.

What is Altimmune's clinical focus mentioned in this announcement?

Altimmune is described as a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases.